|Articles|October 19, 2019
Spray drying for enhancing the solubility of poorly soluble drugs
Spray drying continues to gain importance as a preferred manufacturing technology for amorphous solid dispersions (ASD). A fast carrier selection allows for a more targeted development process with reduced time to market. EUDRAGIT® polymers have not only been proven to be superior with respect to ASD formations but can also stabilize the amorphous state of the API over storage.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
2
New Targets for Clinical Trials in the European Union
3
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
4
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
5
